Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 22, 1988 - Issue 4
Submit an article Journal homepage
6
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Expression of ABH Blood Group Isoantigen as a Prognostic Factor in Transitional Cell Bladder Carcinoma

Per-Uno MalmströmDepartment of Urology, University Hospital of Uppsala
,
Christer BuschDepartment of Pathology, University Hospital of Uppsala
,
Bo Johan NorlenDepartment of Urology, University Hospital of Uppsala
&
Bertil AnderssonDepartment of Statistics, University of Uppsala, Sweden
Pages 265-270 | Received 17 Sep 1987, Published online: 15 Feb 2010

REFERENCES

  • Althausen AF, Prout GR, Daly JJ. Noninvasive papillary carcinoma of the urinary bladder associated with carcinoma in situ. J Urol 1976; 116: 575–580.
  • Anderström C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol 1980; 124: 41–43.
  • Borgström E, Gustafson H. ABH isoantigens in bladder carcinoma, patients grouped according to DNA changes over time. Scand J Urol Nephrol 1987; 21: 125–130.
  • Busch C, Engberg A, Norlen BJ, Stenkvist B. Malignancy grading of epithelial bladder tumours. Scand J Urol Nephrol 1977; 11: 143–148.
  • Busch C, Malmström P-U, Norlen BJ, Sällström J, Brodin T, Lundblad A. A grading system for the immunostaining of A, B and H blood group isoantigens in bladder carcinoma. Anticancer Research 1988; 8: 31–38.
  • Cancer Incidence in Sweden 1983, Socialstyrelsen, Stockholm.
  • Catalona WJ. Practical utility of specific red cell adherence test in bladder cancer. Urology 1981; 18: 113–117.
  • Chisholm GD, Hindmarsh JR, Howatson AG, Webb JN, Busuttil A, Hargreave TB, Newsam JE. TNM (1978) in bladder cancer: Use and abuse. Br J Urol 1980; 52: 500–505.
  • Das G, Buxton NJC, Glashan RW. Invasive potential of superficial bladder cancer. A study of the relative merits of predictive parameters. Br J Urol 1985; 57: 32–36.
  • Decenzo JM, Howard P, Irish CE. Antigenic deletion and prognosis of patients with stage A transitional bladder carcinoma. J Urol 1975; 114: 874–878.
  • Fosså SD, Reitan JB, Ons S, Odegaard A, Loeb M. Prediction of tumour progression in superficial bladder carcinoma. Eur Urol 1985; 11: 1–5.
  • Gustafson H, Tribukait B, Esposti PL. DNA profile and tumor progression in patients with superficial bladder tumours. Urol Res 1982; 10: 13–18.
  • Gunter PA, de Abela-Borg J, Pugh RCB. Urothelium and the specific red cell adherence test. Br J Urol 1983; 55: 10–16.
  • Heney NM, Nocks BN, Daly JJ et al. Ta and Tl bladder cancer: Location, recurrence and progression. Br J Urol 1982; 54: 152–157.
  • Jakse G, Hofstädter F, Marberger H. Stage Tl grade III TCC of the urinary bladder. An unfavourable tumour? XX. Kongress der Internationellen Gesellschaft für Urologie, Wien, June 1985.
  • Juhl BR, Hartzen SH, Hainau B. ABH antigen expression in transitional cell carcinomas of the urinary bladder. Cancer 1986; 57: 1768–1775.
  • Kaye KW, Lange PH. Mode of presentation of invasive bladder cancer. Reassessment of the problem. J Urol 1982; 128: 31–33.
  • Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: 250–252.
  • Malmström P-U, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. A retrospective study of 232 patients with >5 years follow-up. Scand J Urol Nephrol 1987; 21: 185–195.
  • Ooms EC, Anderson WA, Alons CL, Boon ME, Veldheizen RW. Analysis of the performance of pathologists in the grading of bladder tumours. Hum Pathol 1983; 14 (2): 140–143.
  • Schade ROK, Swinney J. The association of urothelial abnormalities with neoplasia: A 10-year follow-up. J Urol 1983; 129: 1125–1126.
  • Soloway MS. Editorial comment. J Urol 1984; 131: 256.
  • Stephenson TJ, Williams JL, Gelsthorpe K. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences. Br J Urol 1985; 57: 148–153.
  • Weinstein RS, Miller AW, Coon JS. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma. In: Progress and controversies in oncological urology. New York: Alan R. Liss, 1984: 249–260.
  • Whitmore WF. Bladder cancer; defining the clinical problem. Urology 1984; Suppl to April, Vol XXIII, No 4.
  • Wijkström H, Edsmyr F, Bundh B. The value of preoperative classification according to the TNM-system. Eur Urol 1984; 10: 101–106.
  • Wolf H, Höjgaard K. Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia. Cancer 1983; 51: 1710–1715.
  • Zingg EJ, Wallace DMA. Bladder cancer (Clinical practice in urology). Springer-Verlag, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.